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Com m ent
It is important to study PI-IBS since its underlying mechanisms will help us understand other subtypes of IBS. Although most patients with infectious enteritis recover rapidly without any residual symptoms, some have persistent symptoms for many years and meet the criteria for a diagnosis of IBS. Prospective studies have shown the percentage of infected individuals who develop PI-IBS to vary from 3.7% to 36%. 2 Present report is the follow-up of study from the Walkerton outbreak. 3 This study is the largest and longest prospective community study of PI-IBS ever published. As the authors mentioned, the results can help clinicians to understand the long-term clinical features and to counsel patients on their long-term risk of PI-IBS. Over 8 years of follow-up, the overall prevalence of PI-IBS was 15.4%, which was statistically higher than that of the controls. This implies that most patients with PI-IBS can be improved although a significant minority experiences symptoms which might persist for a long-term period. Therefore, assess-Journal of Neurogastroenterology and Motility ment of predictors in developing PI-IBS is clinically important. In this report, risk factors for persistent symptoms after 8 years from the initial infection were female gender, younger age, prior anxiety or depression and both fever and weight loss during the acute gastroenteritis. Among these, female gender, younger age and weight loss during the acute gastroenteritis were consistent risk factors compared to the previous report of the authors. However, prior anxiety or depression was added in the risk factor. These findings suggest, as with IBS in general, the mechanism for development of PI-IBS to be explained by using a biopsychosocial model which reflects the influences from both the brain and gut. 4 Authors reported an interesting finding that subtypes of PI-IBS were not stable over time. A previous study reported that 63% of cases of PI-IBS following Campylobacter jejuni-associated enteritis met the Rome II criteria for diarrhea-predominant IBS. 5 Present study showed that more than 90% of the patients with diarrhea-predominant IBS in 2002/3 to present with constipation-predominant IBS or unsubtyped IBS in 2008. This observation suggests clinicians to treat the PI-IBS patients with their dominant symptoms.
Authors mentioned several weaknesses of this study as follows. First, only a minority of its participants had a cultureproven infection. Second, only 2,309 of the original 4,315 Walkerton Health Study participants (53.5%) returned for reassessment in 2008. Third, authors were unable to assess rigorously some important aspects of premorbid health, such as previous gastrointestinal symptoms and psychological profile. Besides these limitations, there is not much more message compared with the author's previous reports even though this paper gives valuable data with the long-term follow-up of PI-IBS. And there is no information about newly developed PI-IBS during follow-up periods.
In conclusion, this report gives important messages. Acute gastroenteritis can trigger IBS symptoms that persist for at least 8 years. Characteristics of the host and acute enteric illness can predict the long-term risk of PI-IBS. These data will help clinicians to understand the long-term clinical features of PI-IBS.
